Pre-clinical research
Curcumin boosts immune cell power against tuberculosis
Incubating cells with turmeric compound reduced Mycobacterium tuberculosis infection.
Source: Shutterstock.com
A compound found in turmeric, curcumin, has been found to induce apoptosis in macrophages infected with tuberculosis
Mycobacterium tuberculosis can replicate inside macrophages and inducing apoptosis of these cells can enhance immune response to tuberculosis (TB) infection.
Researchers found they could trigger apoptosis by inhibiting nuclear factor-kappa B (NFκB) activation. The team, led by Xiyuan Bai at the University of Colorado, have now studied the effect of curcumin – a compound in turmeric and a known inhibitor of NFκB activation – on human macrophages infected with M. tuberculosis.
Reporting in Respirology (online, 24 March 2016)[1], the researchers found that incubating cells with curcumin significantly reduced the amount of M. tuberculosis recovered four days after infection. This effect was via inhibition of NFκB, leading to apoptosis and autophagy.
The team says curcumin could become a new immune-enhancing treatment in drug-resistant TB, but further studies are needed to explore its efficacy and safety.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200933
Recommended from Pharmaceutical Press
- Previous
- Next
BNF and BNF for Children
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£138.50Buy now
BNF and BNF for Children
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.
£262.50Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.